Conditional Deletion of Jak2 Reveals an Essential Role in Hematopoiesis Throughout Mouse Ontogeny: Implications for Jak2 Inhibition in Humans

PLoS ONE - United States
doi 10.1371/journal.pone.0059675
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation

Cells
2019English

JAK2 Exon 14 Deletion in Patients With Chronic Myeloproliferative Neoplasms

PLoS ONE
Multidisciplinary
2010English

Cancer Gene Profiling in Non-Small Cell Lung Cancers Reveals Activating Mutations in JAK2 and JAK3 With Therapeutic Implications

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2017English

Impaired Alveologenesis and Maintenance of Secretory Mammary Epithelial Cells in Jak2 Conditional Knockout Mice

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2004English

JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes

International Journal of Toxicology
Toxicology
2015English

JAK2 Mutation Status, Hemostatic Risk Factors and Thrombophilic Factors in Essential Thrombocythemia (ET) Patients

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2011English

Dual Inhibition of Jak2 and STAT5 Enhances Killing of Myeloproliferative Neoplasia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Therapeutic Potential of JAK2 Inhibitors

The Journal of OncoPathology
2013English

Results of a Phase 2 Study of Pacritinib (SB1518), a JAK2/JAK2(V617F) Inhibitor, in Patients With Myelofibrosis

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy